Nitric oxide and pancreatic islet blood flow after induced portal hypertension in rats

Pancreas

Volumn 14, Issue 3, 1997, Pages 280-284

  Jansson, Leif ^a,b   Andersson, Arne ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Blood flow; Nitric oxide; Pancreatic islets Pancreas; Portal hypertension

Indexed keywords

N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIVISION; COLON BLOOD FLOW; CONTROLLED STUDY; DUODENUM; INTESTINE BLOOD FLOW; LIVER BLOOD FLOW; MALE; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS ISLET; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; SPLANCHNIC BLOOD FLOW;

EID: 0030892966     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199704000-00010     Document Type: Article

References (43)

1. Bonner-Weir S. The microvasculature of the pancreas, with special emphasis on that of the islets of Langerhans. Anatomy and functional implications. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas. Biology, pathobiology, and disease, 2nd ed. New York: Raven Press, 1993: 759-68.
2. Thiel A. Untersuchungen über das Gefäss-system des Pankreasläppchens bei verschiedenen Säugern mit besonderer Berücksichtigung der Kapillärknäuel der Langerhansschen Inseln. Z Zellforsch 1954;39:339-72.
3. Lifson N, Kramlinger KG, Mayrand RR, Lender JE. Blood flow through the rabbit pancreas with special reference to the islets of Langerhans. Gastroenterology 1980;79:466-73.
4. Jansson L, Hellerström C. Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabelologia 1983;25:45-50.
5. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metab Rev 1994;4:407-16.
6. Styrud J, Eriksson UJ, Jansson L. A continuous 48-hour glucose infusion in rats causes both an acute and a persistent redistribution of the blood flow within the pancreas. Endocrinology 1992;130: 2692-6.
7. Atef N, Ktorza A, Picon L, Pénicaud L. Increased islet blood flow in obese rats: role of the autonomie nervous system. Am J Physiol 1992;262:E736-40.
8. G-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats. Endocrinology 1994;135:849-53.
9. Murray JP, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958;24:358-67.
10. Kontos HA, Shapiro W, Mauck HP, Patterson JL. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964;37:526-35.
11. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol 1983;244: G52-7.
12. Benoit JN, Barrowman JA, Harper SL, Kvietys PR, Granger DN. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol 1984;247:G486-93.
13. Benoit JN, Zimmerman B, Premen AJ, Go VLW, Granger DN. Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 1986;251:G674-7.
14. Guarner C, Soriano G. Prostaglandins and portal hypertension. Prostaglandins Leuko Essent Fatty Acids 1993;48:203-6.
15. Pak J-M, Lee SS. Glucagon in portal hypertension. J Hepatol 1994;20:825-32.
16. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
17. Förstermann U, Pollock JS, Nakane M. Nitric oxide synthases in the cardiovascular system. Trends Cardiovasc Med 1993;3:104-10.
18. Vallance P, Moncada S. Hypothesis: induction of nitric oxide synthase in the vasculature underlies the hyperdynamic circulation of cirrhosis. Lancet 1991;337:776-8.
19. Piszueta P, Pique JM, Bosch J, Whittle BJ, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105:184-90.
20. Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993;104:1750-4.
21. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994;20:1343-50.
22. Konturek SJ, Bilski J, Konturek PK, Cieszkowski M, Pawlik W. Role of endogenous nitric oxide in the control of canine pancreatic secretion and blood flow. Gastmenterology 1993;104:896-902.
23. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using labeled microspheres. Am J Physiol 1981;240:G371-5.
24. Jansson L, Hellerström C. A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres. Acta Physiol Scand 1981;113:371-4.
25. Swenne I, Andersson A. Effect of genetic background on the capacity for islet cell replication in mice. Diabetologia 1984;27: 446-9.
26. Mellgren A, Schnell Landström A, Petersson B, Andersson A. The renal subcapsular site offers better growth conditions for transplanted mouse pancreatic islet cells than the liver or spleen. Diabetologia 1986;29:670-2.
27. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985;248:G618-25.
28. Lee FY, Colombato LA, Albillos A, Groszmann RJ. Administration of N-omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993;105: 1464-70.
29. Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology 1993;18:1416-21.
30. Garcia-Pagan JC, Fernandez M, Bernadich C, et al. Effects of continuous NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. Am J Physiol 1994;267:G984-90.
31. Sieber CC, Groszmann RJ. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992;262:G996-1001.
32. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992;103:235-9.
33. Karatapanis S, McCormick PA, Kakad S, et al. Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats. Hepatology 1994;20:1516-21.
34. Piszueta P, Piqué JM, Fernández M, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1909-15.
35. Casadevall M, Panes J, Pique JM, Marroni N, Bosch J, Whittle BJ. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology 1993;18:628-34.
36. Sitzmann JV, Li S-S, Lin P-W. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension. J Surg Res 1989;47:208-11.
37. Romeo JM, Lopez-Farre A, Matin-Paredero V, Lopez-Novoa JM. Role of glucagon in the splanchnic and systemic hemodynamic changes induced by portal-systemic blood shunting. Clin Physiol Biochem 1990;8:144-52.
38. Jansson L, Hellerström C. Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system. Am J Physiol 1986;251:E644-7.
39. Abergel A, Braillon A, Gaudin C, Kleber G, Lebrec D. Persistence of hyperdynamic circulation in cirrhotic rats following removal of the sympathetic nervous system. Gastroenterology 1992;102:656-60.
40. Shmueli E, Record CO, Alberti KGMM. Liver disease, carbohydrate metabolism and diabetes. Ballieres Clin Endocrinol Metab 1992;6:719-43.
41. Sikuler E, Polio J, Groszmann RJ, Hendler R. Glucagon and insulin metabolism in a portal-hypertensive rat model. Am J Physiol 1987;253:G110-5.
42. Wu J, Lindström P, Danielsson Å, Sehlin J. Insulin secretion in pancreatic islets from rats with cirrhosis. J Hepatol 1994;21:332-9.
43. Gomis R, Fernández-Alvarez J, Piszueta P, Fernández M, Casamitjana R, Bosch J. Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation. Hepatology 1994;19:1257-61.